GlaxoSmithKline Plc
Hualan Biological Engineering Inc. Incepta Pharmaceuticals Limited
Novartis AG
Pfizer Inc. Sanofi S.A. Serum Institute of India Ltd. and Walvax Biotechnology Co. Ltd.
Published | Pages | Publisher | Report code |
---|---|---|---|
Nov 2023 | 149 | iMarc Group | ASDR-639903 |
GlaxoSmithKline Plc
Hualan Biological Engineering Inc. Incepta Pharmaceuticals Limited
Novartis AG
Pfizer Inc. Sanofi S.A. Serum Institute of India Ltd. and Walvax Biotechnology Co. Ltd.